Pmv Pharmaceuticals, Inc. · NASDAQ:PMVP
Pmv Pharmaceuticals, Inc. shareholders
As of Jun 30, 2026, 62 institutions reported holding Pmv Pharmaceuticals, Inc., 64.7% of its shares. Largest: BML Capital Management, LLC, Tang Capital Management LLC and Sio Capital Management, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Pmv Pharmaceuticals, Inc. | Change | Filed |
|---|---|---|---|---|
| BML Capital Management, LLC | 5.33M | 10.0% | +10,000 | Aug 7, 2026 |
| Tang Capital Management LLC | 4.25M | 7.9% | no change | Aug 14, 2026 |
| Sio Capital Management, LLC | 2.63M | 4.9% | −442K | Aug 14, 2026 |
| Euclidean Capital LLC | 2.63M | 4.9% | no change | Aug 14, 2026 |
| Adage Capital Partners Gp, L.L.C. | 2.36M | 4.4% | +500K | Aug 14, 2026 |
| Vanguard | 2.29M | 4.3% | −6,237 | Aug 13, 2026 |
| Acadian Asset Management LLC | 2.22M | 4.1% | no change | Aug 13, 2026 |
| ArrowMark Colorado Holdings LLC | 1.96M | 3.7% | held for review | Aug 13, 2026 |
| Two Sigma | 1.95M | 3.7% | +69,606 | Aug 14, 2026 |
| Eversept Partners, LP | 1.89M | 3.5% | −457K | Aug 14, 2026 |